P 2021

Thermostable FGF2 Polypeptide, Use Thereof

DVOŘÁK, Petr; Pavel KREJČÍ; Lukáš BÁLEK; Lívia EISELLEOVÁ; Žaneta KONEČNÁ et. al.

Basic information

Original name

Thermostable FGF2 Polypeptide, Use Thereof

Authors

DVOŘÁK, Petr; Pavel KREJČÍ; Lukáš BÁLEK; Lívia EISELLEOVÁ; Žaneta KONEČNÁ; Pavel DVOŘÁK; David BEDNÁŘ; Jan BREZOVSKÝ; Eva ŠEBESTOVÁ; Radka CHALOUPKOVÁ; Veronika ŠTĚPÁNKOVÁ; Pavel VAŇÁČEK; Zbyněk PROKOP; Jiří DAMBORSKÝ and Michaela BOSÁKOVÁ

Edition

Number: SG11201804402W, Publisher: Intellectual Property Office of Singapore (IPOS), Place of publication: Singapur, Owner's name: Masarykova univerzita; Enantis s.r.o. 2021

Other information

Language

English

Type of outcome

Patent

Country of publisher

Singapore

Confidentiality degree

is not subject to a state or trade secret

References:

RIV identification code

RIV/00216224:14310/21:00121632

Organization

Přírodovědecká fakulta – Repository – Repository

Keywords in English

Fibroblast Growth Factor 2; FGF2

Links

LO1214, research and development project.
Changed: 1/6/2022 02:28, RNDr. Daniel Jakubík

Abstract

In the original language

The invention provides an isolated thermostable polypeptide possessing FGF2 activity and having at least 85% sequence identity to SEQ ID NO: 2 (FGF2 wt) or a functional fragment thereof, and comprising at least one amino acid substitution R31L and the use thereof in the cell biology research, regenerative medicine and related medical applications or cosmetics. Further it discloses a culture medium comprising subjected FGF2 suitable for culturing a human pluripotent stem cells involving both human embryonic stem cells and induced pluripotent stem cells.

Files attached